[Local treatment of malignant pleural effusion in gynecologic tumors].
Pleural effusions are a frequent complication of malignant gynecologic diseases, especially in breast cancer with an incidence of about 50%. Pleural effusions usually occur at a stage of the disease where no further curative therapeutic options exist. Therefore, the treatment should be effective and have a low side effect profile. The intrapleural administration of mitoxantrone in comparison with other pleurodesis techniques has been demonstrated to meet these requirements.
Frauenklinik und Hebammenlehranstalt, Georg-August-Universität, Göttingen.
D
D
Seitzer
E
E
Musch
W
W
Kuhn
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008942:Mitoxantrone / Q000008:administration & dosage*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D010166:Palliative Care; D010996:Pleural Effusion / Q000188:drug therapy; D010997:Pleural Neoplasms / Q000188:drug therapy / Q000556:secondary*; D015996:Survival Rate
D008942:Mitoxantrone
Die lokale Behandlung maligner Pleuraergüsse bei gynäkologischen Tumoren.